Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9NQ4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $61,021
Award facts
- Contract value 100% obligated
- $61,021.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $61,021.24 delivery order to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 mL pens on January 29, 2026, with a completion date of January 30, 2026. This competitive, firm fixed-price contract requires performance at the awardee's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The delivery order operates under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which provides a comprehensive vehicle for supplying pharmaceuticals and medical supplies to support military healthcare programs globally.
Zepbound, a weight management medication, represents one of many pharmaceutical products delivered through this strategic partnership supporting the Defense Health Agency and other government healthcare systems. As a non-set-aside award, this delivery order reflects AmerisourceBergen's continued competitive capability to fulfill federal medical supply requirements. The parent company, Cencora, Inc., maintains an even larger IDC with the DLA valued at up to $999,999,999.00 through December 31, 2031, underscoring the critical role this pharmaceutical distributor plays in the federal supply chain for military medical operations.
Quick answers
Who was awarded contract SPE2DR26F9NQ4?
SPE2DR26F9NQ4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F9NQ4 worth?
The government has obligated $61,021 on SPE2DR26F9NQ4.
Is contract SPE2DR26F9NQ4 an order under another contract?
Yes. SPE2DR26F9NQ4 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9NQ4 competed?
The extent of competition for SPE2DR26F9NQ4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award